IPO Top 10 Articles on GenomeWeb in 2021 The most-read stories in 2021 represents readers' vast interests in the variety of topics covered by GenomeWeb from COVID-19 tests to IPOs and legal battles. German MDx Firm Mainz Biomed Raises $10M in IPO, Begins Trading on Nasdaq The company, which has been developing a colorectal cancer diagnostic called ColoAlert, priced its IPO last week, offering 2 million shares at $5 per share. MDxHealth Prices IPO of American Depositary Shares The diagnostics company is offering 3.75 million ADSs at $12 per share and is hoping to raise gross proceeds of $45 million. Lucid Diagnostics Prices $70M IPO, Starts Trading on Nasdaq Lucid markets an esophageal DNA test and cell collection device for the detection of gastroesophageal reflux disease, and esophageal precancer and cancer. MDxHealth Files for IPO of American Depositary Shares The company, which confidentially submitted a draft registration statement to the SEC in September, has now publicly filed for listing on the Nasdaq. Oct 8, 2021 IsoPlexis Raises $125M in IPO Oct 5, 2021 Genetic Analysis Raises $6.8M in Oversubscribed IPO Sep 16, 2021 Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle Sep 14, 2021 Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger Sep 13, 2021 Oxford Nanopore Technologies Registers for IPO on London Stock Exchange Sep 2, 2021 Cue Health Files for IPO for up to $100M Sep 1, 2021 MDxHealth Files for IPO of American Depository Shares Aug 27, 2021 SeqLL to Go Public in $13M IPO Jul 23, 2021 Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships Jul 23, 2021 Cytek Biosciences Prices $200M Initial Public Offering Jul 19, 2021 Sophia Genetics Increases IPO Target to $221M Jul 6, 2021 Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare Jul 2, 2021 Caribou Biosciences Files for $100M IPO Jun 23, 2021 Codex DNA Closes $122.7M IPO May 27, 2021 Singular Genomics Systems Raises $258M in Upsized IPO May 24, 2021 Singular Genomics Ups IPO Target to $187M May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Apr 28, 2021 Post-IPO, Talis Biomedical Looks Toward Expanding Infectious Disease Test Portfolio Premium Mar 30, 2021 Oxford Nanopore Technologies to File for IPO in Second Half of 2021 Mar 12, 2021 Prometheus Biosciences Prices Upsized $190M IPO Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.